Post by
SPCEO1 on Jan 15, 2021 7:03pm
Why did they do this horrible offering?
WIth the selling after hours, it is hard not to add some paranoia to the stages of grief we ae dealign with already. So, does anyone have a decent theory about why an otherwise sensible group of people who clearly know better than to issue shares on such awful terms went ahead and did so anyway? Here is my offerings on that but I must not be seeing something and I hope someone else will:
1.) The easist explanation is they have been wanting to do this for a while and thought the bubble was about to burst, potentially cutting off funding for a while. Given that share sales were going on hot and heavy last April at the height of the covid panic, however, that would seem to be a big overreaction to a possible scenario that may not materialize for a while.
2.) When reading the prospectus, it is perfectly clear they are having an issue getting the EMA on board. They are still "assessing their strategy" regarding the EMA according to the prospectus and since they have had so much time to interact with them already, that can only mean there is a high probability of the EMA not giving TH a thumbs up on the phase III. With questions still looming at the FDA, they knew that could call the whole NASH program into question in investors minds and wanted to raise money while everyone still thought all was well on the NASH phase III front. That would be quite a deception but the way things went down with the deal being announced just 2 days after the "good news" on the FDA letter, with no US brokers involved, and on horrible terms led by a second tier Canadian briker, it sure smells like that.
We had said that it was key for Paul and the company to get this phase III thing done or their credibility would be mud. Perhaps this is why they moved to raise money in this atrocious way since they knew their credibility would soon be in tatters?
Comment by
realitycheck4u on Jan 15, 2021 7:58pm
This post has been removed in accordance with Community Policy
Comment by
Bucknelly21 on Jan 15, 2021 8:17pm
Let's be honest they just aren't that good at anything that has to do with marketing... you can have the best product in the world but if know one knows about it or you can't sell it what good is it actually...
Comment by
scarlet1967 on Jan 15, 2021 9:24pm
This is the part they are lagging compared with other companies in the same space.
Comment by
ggg088 on Jan 15, 2021 9:36pm
They should move the HQ to the US.
Comment by
Bucknelly21 on Jan 15, 2021 9:55pm
Unfortunately it appears to be the main problem for us and honestly I don't see them changing with as much as I want to
Comment by
jeffm34 on Jan 15, 2021 11:17pm
If the Phase 3 trial does not get the go ahead they have opened themselves up to a major lawsuit from those that bought after the announcement. You would hope they'd be well aware of that but given their recent judgement who knows.
Comment by
SPCEO1 on Jan 15, 2021 11:26pm
Read the prospectus, they told you that these risks are there, so they should not lose a lawsuit. Still, I don't think they lose the FDA backing for the phase III. Just the EMA looks sketchy.